Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of SID530 vs Taxotere in Advanced NSCLC or Breast Cancer
NCT00931008Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Oct 2009
- Primary completion
- Jan 2011
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of docetaxel in non-small cell lung cancer (NSCLC), breast cancer, sponsored by SK Chemicals. Started Oct 2009; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)breast cancer
Beyond the preview
Go deeper on NCT00931008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931008.